Company
Funding data: Recent Funding. Each amount links to the announcement it came from.
Immunomatics
Immunomatics is a healthtech company developing AI software to predict donor-recipient compatibility risk.
Rounds
| Date | Stage | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 6, 2026 | Seed | $100k | — | Myosotis Investments | prnewswire.com ↗ |
About
- Website
- immunomatics.com
- Based in
- San Marcos, United States
Founders
- Lidio MeirelesFounder & CEO
Investors
Myosotis Investments · National Institutes of Health